Free Trial

Actuate Therapeutics (ACTU) Earnings Date, Estimates & Call Transcripts

Actuate Therapeutics logo
$8.86 +0.28 (+3.26%)
(As of 10:25 AM ET)

Actuate Therapeutics Latest Earnings Summary

Upcoming Q3
Earnings Date
Dec. 24Estimated
Actual EPS
(Sep. 24)
-$4.20 Missed By -$4.20

Actuate Therapeutics posted Q2 2024 earnings on September 24, 2024, reporting an EPS of -$4.20. Actuate Therapeutics currently has a trailing EPS of $0.00

ACTU Upcoming Earnings

Actuate Therapeutics' next earnings date is estimated for Tuesday, December 24, 2024, based off prior year's reporting schedules.

Get Actuate Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Actuate Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ACTU Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ACTU Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Actuate Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
12/24/2024
(Estimated)
------- 
9/24/2024Q2 2024--$4.20 -$4.20-$4.20--
7/23/2024Q1 2024--$5.40 -$5.40-$5.40--


This page (NASDAQ:ACTU) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners